Stifel analyst Alex Thompson reiterated a Buy rating and $58.00 price target on Crinetics (NASDAQ: CRNX).The analyst commented, "Paltusotine (Palsonify) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE